In gallbladder cancer, SIRT3 was found to promote ferroptosis by activating the AKT signaling pathway [14], but in another study, SIRT3 was shown to have an inhibitory role in ferroptosis in human cancer cells in a p53-dependent manner [15]. This evidence concerns the gene SIRT3 and cancer.